BRIEF published on 06/10/2026 at 20:18, 14 days 10 hours ago Poxel appoints Yves Decadt as its new Chief Executive Officer Strategic Partnerships Biopharmaceutical Continuation Plan Poxel Yves Decadt
BRIEF published on 06/10/2026 at 20:18, 14 days 10 hours ago Poxel Appoints Yves Decadt as CEO to Advance Strategic Goals Strategic Partnerships Biopharmaceutical Poxel Imeglimin Yves Decadt
PRESS RELEASE published on 06/10/2026 at 20:13, 14 days 10 hours ago Inside Information / Other news releases Poxel appoints Yves Decadt as Chief Executive Officer to accelerate portfolio development and strategic partnerships. Yves Decadt brings over 25 years of international pharmaceutical industry experience Strategic Partnerships Chief Executive Officer Portfolio Development Poxel Yves Decadt
BRIEF published on 03/31/2026 at 13:12, 2 months 24 days ago Poxel sells the PXL770 to Scynexis for a potential value of $196 million Financial Agreement Poxel PXL770 SCYNEXIS Polycystic Kidney Disease
BRIEF published on 03/31/2026 at 13:12, 2 months 24 days ago Poxel Sells PXL770 to Scynexis for Up to $196 Million Biopharmaceutical Poxel PXL770 SCYNEXIS ADPKD
PRESS RELEASE published on 03/31/2026 at 13:07, 2 months 24 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Poxel announces sale of PXL770 for up to $196 million to SCYNEXIS. PXL770 targets ADPKD. Agreement includes upfront payment, development and commercial milestones. Phase 2 study planned for Q4 2026 Milestones Poxel PXL770 SCYNEXIS ADPKD
BRIEF published on 03/25/2026 at 22:03, 2 months 30 days ago Poxel Secures Additional Financing Through New Tranche D PDR Bonds Financing Continuation Plan Poxel IPF Partners Tranche D PDR
PRESS RELEASE published on 03/25/2026 at 21:58, 2 months 30 days ago Inside Information / News release on accounts, results Poxel confirms drawdown under Tranche D PDR bond issue for €3.75 million with IPF as part of continuation plan validated by Lyon Commercial Court. Key details and financing prospects outlined Financing Opportunities Poxel IPF Partners Tranche D PDR
BRIEF published on 02/03/2026 at 08:45, 4 months 21 days ago Poxel Establishes Equity Line with IRIS Capital Financing Recovery Plan Equity Line Poxel IRIS Capital
PRESS RELEASE published on 02/03/2026 at 08:40, 4 months 21 days ago Inside Information / Other news releases Poxel announces implementation of equity line with IRIS Capital as part of recovery plan. New financing structure to enhance financial foundation Financial Structure Recovery Plan Equity Line Poxel IRIS Capital
Published on 06/25/2026 at 00:30, 6 hours 21 minutes ago Northern Dynasty Reports Annual General Meeting Results and Welcomes New Directors
Published on 06/24/2026 at 23:05, 7 hours 46 minutes ago Polaris Modifies Quorum Requirement for Upcoming AGM
Published on 06/24/2026 at 22:15, 8 hours 36 minutes ago Organto Foods Announces Annual General Meeting Results
Published on 06/24/2026 at 21:20, 9 hours 31 minutes ago Taranis to Explore New Properties East of Thor Mineral Resource
Published on 06/24/2026 at 20:10, 10 hours 41 minutes ago Fox River Obtains Final Order Approving Plan of Arrangement With Avenir Minerals Limited
Published on 06/25/2026 at 03:20, 3 hours 31 minutes ago ZTT at Intersolar Europe 2026: Full-Industry-Chain Strength Powering a Low-Carbon Future
Published on 06/24/2026 at 23:57, 6 hours 54 minutes ago OHB: Upsized private placement worth EUR 900 million successfully completed
Published on 06/24/2026 at 20:54, 9 hours 56 minutes ago EQS-Adhoc: Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/24/2026 at 18:25, 12 hours 26 minutes ago Huawei Helps Global Carriers Monetize Tokens with Service-Network-Compute Integration
Published on 06/24/2026 at 17:45, 13 hours 6 minutes ago Air Liquide continues its long-term growth in Kazakhstan with a key investment to support Silleno's world-scale plant
Published on 06/24/2026 at 17:40, 13 hours 11 minutes ago Report on share repurchases from 17 to 23 June 2026
Published on 06/24/2026 at 16:21, 14 hours 30 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of May 31, 2026
